Cart
sales@molnova.com
CCT077791
CAS No. 748777-47-1
CCT077791( —— )
Catalog No. M34060 CAS No. 748777-47-1
CCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 1398 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCCT077791
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
-
DescriptionCCT077791 is a potent inhibitor of p300 and PCAF histone acetyltransferase activity for cancer research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEpigenetic Reader Domain | Histone Acetyltransferase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number748777-47-1
-
Formula Weight256.67
-
Molecular FormulaC9H5ClN2O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1N(SC(Cl)=C1)C2=CC=C(N(=O)=O)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Menin-MLL inhibitor ...
Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).
-
FHT-1015
FHT-1015 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with potential anticancer activity for the study of cancer and inflammation.
-
Butyrolactone 3
Butyrolactone 3 (MB-3) is a histone acetyltransferase Gcn5 inhibitor with a weak affinity for CBP.Butyrolactone 3 has antimicrobial activity and has been used in cancer, metabolic and neurological disorders.
